Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • 13 - Drugs in the elderly

  • Leanne Teoh, University of Melbourne, Geraldine Moses, University of Queensland, Michael McCullough, University of Melbourne
  • Book:
    Handbook of Dental Therapeutics
    Published online:
    23 February 2024
    Print publication:
    14 March 2024, pp 259-278

  • Summary

    A hallmark of the 21st century is that people are living longer than ever before, making it increasingly likely that dental patients are in their later years. In 2020, the proportion of Australians aged 65 years and older reached 16.3%, increasing from 12.4% in 2000, and it is currently predicted to reach ~25% by 2050. Meanwhile, people aged 85 years and over are in the fastest growing sector, increasing by 2.5% in 2020 alone, and by 110% over the preceding 20 years, compared with growth of only 35% for the total population over the same period. Caring for older patients with ageing oral health is an increasing challenge for dental practitioners. In addition to living longer, older Australians are retaining their own teeth for longer. Changes in the oral cavity due to ageing reflect changes throughout the rest of the body, such as loss of elasticity, decreased muscle tone and degradation of hard and soft tissues due to wear and tear. With greater likelihood of medical diagnoses and prescription of medications, healthcare of older patients becomes more complex. Many age-related changes in physiology alter the pharmacokinetics and pharmacodynamics of medicines in older people.

  • Benzodiazepines prescribing in eldery patients: A study about the prescribing behaviour of tunisian psychiatrists

  • M. Lagha, U. Ouali, F. Nacef
  • Journal:
    European Psychiatry / Volume 64 / Issue S1 / April 2021
    Published online by Cambridge University Press:
    13 August 2021, p. S428
    • Article
      • You have access
      • Open access
    • PDF
    • Export citation
  • Introduction

    Prescribing benzodiazepines (BZD) in patients over 65 years old requires special precautions in view of the frequency and the severity of their side effects, especially in this age group.

    Objectives

    The objectives of our work were to evaluate the modalities of BZDs prescribing in elderly patients in psychiatry and to assess their compliance with international recommendations.

    Methods

    This is a descriptive cross-sectional study conducted through a Google-forms self-administered questionnaire, intended for psychiatrists and psychiatric residents, over a period of two months, from April 1 to May 31, 2019.

    Results

    One hundred physicians practicing in psychiatry answered our questionnaire. The response rate was 28%. Special precautions were taken in elderly patients by 96.5% of the participants. In eldery patients, long half-life BZDs were prescribed in 15% of cases. The majority of the participants indicated that the risk of falls (98.1%) and memory impairments (75.2%) were the main risks to which they were particularly vigilant during the prescribing of BZDs in eldery patients. In the elderly, 20% of the participants said they did not take special precautions when stopping BZDs.

    Conclusions

    The frequency and severity of side effects associated with BZDs in the elderly are the cause of strict prescribing rules in this age group. According to the results of our study and to the literature data, the prescribing practices of these molecules in the elderly remain insufficiently in accordance with the guidelines.